fludarabine phosphate has been researched along with Opportunistic Infections in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerrits, WB; Haak, HL; Wijermans, PW | 1 |
| Albo, C; Benítez, E; Constenla, MI; Plaza, J; Poderós, C | 1 |
| Schilling, PJ; Vadhan-Raj, S | 1 |
| Bastion, Y; Bryon, PA; Coiffier, B; Espinouse, D; Tigaud, JD | 1 |
4 other study(ies) available for fludarabine phosphate and Opportunistic Infections
| Article | Year |
|---|---|
Severe immunodeficiency in patients treated with fludarabine monophosphate.
Topics: Adult; Aged; Bone Marrow; Female; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Opportunistic Infections; T-Lymphocyte Subsets; Vidarabine Phosphate | 1993 |
[Peritoneal tuberculosis in a patient with chronic lymphatic leukemia in treatment with fludarabine].
Topics: Adenosine Deaminase; Aged; Biomarkers; False Negative Reactions; Fatal Outcome; Female; Humans; Immunity, Cellular; Immunocompromised Host; Opportunistic Infections; Peritonitis, Tuberculous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tuberculin Test; Vidarabine Phosphate | 1996 |
Concurrent cytomegalovirus and pneumocystis pneumonia after fludarabine therapy for chronic lymphocytic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleotides; Cytomegalovirus Infections; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Vidarabine Phosphate | 1990 |
Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia.
Topics: Aged; Female; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Opportunistic Infections; Pneumonia, Pneumocystis; Vidarabine Phosphate | 1991 |